IMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effec...

FDA Device Recall #Z-1069-2013 — Class II — March 15, 2013

Recall Summary

Recall Number Z-1069-2013
Classification Class II — Moderate risk
Date Initiated March 15, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm AGFA Corp.
Location Greenville, SC
Product Type Devices
Quantity 2

Product Description

IMPAX CV 7.8 SU3 - OCR Service. The IMPAX CV Reporting component facilitates the quick , effective creation of digital structured reports for adult catheterization and echocardiography, pediatric echocardiography, congenital heart disease, nuclear cardiology and non-invasive vascular disease management.

Reason for Recall

Software design error in IMPAX CV 7.8 SU3

Distribution Pattern

Distribute in the state of FL and KY

Lot / Code Information

Softwaer version: IMPAX CR 7.8 SU3 Optical Character Recognition (OCR) Service

Other Recalls from AGFA Corp.

Recall # Classification Product Date
Z-2081-2014 Class II AGFA Digital Radiography X-Ray system DX-D 100 ... Jun 6, 2014
Z-1662-2014 Class II IMPAX CV Pediatric Echo Reporting, IMPAX CV Ech... Apr 30, 2014
Z-0919-2014 Class II IMPAX RIS QDOC 5.8 Jan 8, 2014
Z-0035-2014 Class II IMPAX 5.2 DB Server (running Oracle 10.1.0.4.0)... Sep 19, 2013
Z-1487-2013 Class II AGFA Digital Radiography X-Ray System DX-D 100 ... May 15, 2013

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.